跳至主要内容
临床试验/NL-OMON40818
NL-OMON40818已完成2 期

The effects of BCG-vaccination on the immune response induced by influenza-vaccination in healthy volunteers. A pilot proof-of-principle study. - Effects of BCG on influenza-induced immune response

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >=18 and <=35 yrs or >=65 yrs

排除标准

  • - Prior exposure to *Influvac* influenza virus strains , measured by antibody titres. Previous exposure is defined by antibody titres >=1:40.
  • - History of influenza vaccination within the year prior to study entry
  • - History of BCG vaccination within 5 years prior to study entry
  • - History of Mantoux testing within the year prior to study entry
  • - Vaccination other than BCG or influenza, within 3 months prior to study or within study period
  • - Medical history of any disease associated with immune deficiency
  • - Clinically significant acute illness, including infections, within 4 weeks before vaccination
  • - Participation in a drug trial or donation of blood 3 months prior to study entry
  • - Use of recreational drugs within 21 days prior to experiment day
  • - Recent hospital admission or surgery with general anaesthesia (<3 months)
  • - Known chronic kidney or liver disease
  • - Latent or active tuberculosis infection

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验